SEP 20, 2017 10:32 AM PDT

Inflammatory Cells Transformed Into 'Beneficial Weapons' To Heal Brain Damage

WRITTEN BY: Kara Marker

Specialized immune cells called neutrophils are the first responders to invading pathogens, releasing toxic chemicals and recruiting other immune cells to help. But when neutrophils are called to the brain where there’s intracerebral bleeding but no infection, their toxic chemicals make the brain injury worse.

Head MRI showing deep intracerebral hemorrhage (cerebellum). Credit: WIkimedia User Bobjgalindo

From the University of Texas Health Science Center at Houston (UTHealth), scientists discovered that neutrophils could be transformed from harmful instigators into “chemical weapons” to help people recovering from hemorrhagic stroke, which causes bleeding in the brain.

"This is one of the first discoveries showing that you can train neutrophils to act as friendly cells,” explained senior author Jaroslaw Aronowski, MD, PhD.

Hemorrhagic stroke occurs when a weakened artery inside the brain leaks or ruptures into the tissue, compressing the brain and causing damage. Arteries rupture either due to aneurysm, a weak area in the blood vessel that bulges until it ruptures, or arteriovenous malformations, abnormally formed blood vessels that are prone to rupture.

After ischemic stroke, hemorrhagic stroke is the second most common type of stroke, causing 13 percent of all strokes. Half of all hemorrhagic stroke patients die within the first two days.

The breakdown of red blood cells during hemorrhagic leads to iron toxicity, ultimately resulting in oxidative stress, inflammation, and continuous cell damage. However, neutrophils are capable of releasing lactoferrin, which binds iron. Meanwhile, the brain and spleen release interleukin-28, a chemical messenger that relays this message to neutrophils: produce even more lactoferrin.

Alongside manipulating neutrophil activity in the brain with interleukin-28, Aronowski and his team believe that treatment with lactoferrin could be a super effective new therapeutic approach to treating hemorrhagic stroke.

“We've adapted how the body already responds naturally but it can take 12 to 18 hours for the signal to turn them from damaging neutrophils to the beneficial cells that release lactoferrin and by then, it can be too late,” Aronowski explained.

Now, the team is working on creating an even better form of lactoferrin that can cross the blood brain barrier to bind iron even faster and more effectively.

The present study was published in the journal Nature Communications.

Sources: American Stroke Association, University of Texas Health Science Center at Houston

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 01, 2018
Neuroscience
NOV 01, 2018
How baroreceptors do blood pressure sensing
mechanical changes in the blood vessels is communicated to brain via mechanosensitive Piezo ion channels...
NOV 11, 2018
Health & Medicine
NOV 11, 2018
Stop Procrastinating, It's Not Good for You
Procrastination is common, but some people procrastinate much more than others. Those who do it persistently probably exhibit something known as chronic pr...
NOV 13, 2018
Neuroscience
NOV 13, 2018
Perineuronal nets and Epilepsy
Perineuronal nets (PNNs), a specialized extracellular matrix structures that surround the cell bodies and proximal...
NOV 23, 2018
Cannabis Sciences
NOV 23, 2018
Our Endocannabinoid System and Appetite
The Thanksgiving holiday is a perfect time to discuss science. Particularly, the science of appetite. While the old wives' tale of the tryptophan in tu...
DEC 17, 2018
Drug Discovery
DEC 17, 2018
Alzheimer Preventing Drug Could Work Like A Vaccine
Researchers at UT Southwestern believe that a protein called ApoE is the primary factor in late-onset Alzheimer's disease. Such conclusion has to inspi...
DEC 17, 2018
Health & Medicine
DEC 17, 2018
Light Makes An Itch Go Away!
EMBL researchers have now found a way to stop itch with light in mice. Nature Biomedical Engineering publishes their results on 17 December 2018....
Loading Comments...